77 related articles for article (PubMed ID: 23589995)
21. Cervical screening in the UK and laboratory quality control in the context of the 2007 European guidelines.
Herbert A
Coll Antropol; 2007 Apr; 31 Suppl 2():41-6. PubMed ID: 17598504
[TBL] [Abstract][Full Text] [Related]
22. The use of cervical screening history data to interpret cervical cancer incidence trends.
Clare J; Edwards D; Bagnall H; Pearmain P; Lawrence G
J Public Health (Oxf); 2008 Jun; 30(2):171-7. PubMed ID: 18296455
[TBL] [Abstract][Full Text] [Related]
23. Cervical cancer still presents symptomatically 20 years after the introduction of a structured national screening programme.
Myriokefalitaki E; Potdar N; Barnfield L; Davies Q; Moss EL
Cytopathology; 2016 Aug; 27(4):229-36. PubMed ID: 26919275
[TBL] [Abstract][Full Text] [Related]
24. Cervical cancer screening. Organised screening to avoid unnecessary conisation.
Prescrire Int; 2010 Aug; 19(108):172-7, 179. PubMed ID: 20939454
[TBL] [Abstract][Full Text] [Related]
25. A retrospective study of cervical screening in women under 25 years (2005-2009).
Ali AA; Richardson D; Hill N
Arch Gynecol Obstet; 2013 Apr; 287(4):765-9. PubMed ID: 23183714
[TBL] [Abstract][Full Text] [Related]
26. Implementing the national invasive cervical cancer audit: a local perspective.
Moss EL; Pearmain P; Askew S; Owen G; Reynolds TM; Prabakar IM; Douce G; Parkes J; Menon V; Todd RW; Redman CW
BJOG; 2010 Oct; 117(11):1411-6. PubMed ID: 20716252
[TBL] [Abstract][Full Text] [Related]
27. Cervical cancer screening among low-income women: results of a national screening program, 1991-1995.
Lawson HW; Lee NC; Thames SF; Henson R; Miller DS
Obstet Gynecol; 1998 Nov; 92(5):745-52. PubMed ID: 9794662
[TBL] [Abstract][Full Text] [Related]
28. The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications.
Hall MT; Smith MA; Lew JB; O'Hallahan J; Fentiman G; Neal H; Sage M; Canfell K
Gynecol Oncol; 2019 Mar; 152(3):472-479. PubMed ID: 30876491
[TBL] [Abstract][Full Text] [Related]
29. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group.
Sasieni PD; Cuzick J; Lynch-Farmery E
Br J Cancer; 1996 Apr; 73(8):1001-5. PubMed ID: 8611418
[TBL] [Abstract][Full Text] [Related]
30. Implementation of HPV-based cervical cancer screening in an organised regional screening programme: 3 years of experience.
Veijalainen O; Kares S; Kujala P; Vuento R; Osuala V; Tirkkonen M; Luukkaala T; Kholová I; Mäenpää J
Cytopathology; 2019 Mar; 30(2):150-156. PubMed ID: 30421573
[TBL] [Abstract][Full Text] [Related]
31. A review of cervical cancer patients presenting in Harare and Parirenyatwa Hospitals in 1998.
Chirenje ZM; Rusakaniko S; Akino V; Mlingo M
Cent Afr J Med; 2000 Oct; 46(10):264-7. PubMed ID: 11682933
[TBL] [Abstract][Full Text] [Related]
32. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
Malagón T; Kulasingam S; Mayrand MH; Ogilvie G; Smith L; Bouchard C; Gotlieb W; Franco EL
Lancet Oncol; 2018 Dec; 19(12):1569-1578. PubMed ID: 30392810
[TBL] [Abstract][Full Text] [Related]
33. Cervical cancer screening and registration--are they working?
Choyce A; McAvoy BR
J Epidemiol Community Health; 1990 Mar; 44(1):52-4. PubMed ID: 2348149
[TBL] [Abstract][Full Text] [Related]
34. Why Do Women Get Cervical Cancer in an Organized Screening Program in Canada?
Jackson R; Wang L; Jembere N; Murphy J; Kupets R
J Low Genit Tract Dis; 2019 Jan; 23(1):1-6. PubMed ID: 30489433
[TBL] [Abstract][Full Text] [Related]
35. Primary HPV testing: a proposal for co-testing in initial rounds of screening to optimise sensitivity of cervical cancer screening.
Herbert A
Cytopathology; 2017 Feb; 28(1):9-15. PubMed ID: 27005867
[TBL] [Abstract][Full Text] [Related]
36. A comprehensive program for cervical cancer detection and management.
Benedet JL; Anderson GH; Matisic JP
Am J Obstet Gynecol; 1992 Apr; 166(4):1254-9. PubMed ID: 1566781
[TBL] [Abstract][Full Text] [Related]
37. A qualitative study to assess the potential of the human papillomavirus vaccination programme to encourage under-screened mothers to attend for cervical screening.
Spencer AM; Brabin L; Roberts SA; Patnick J; Elton P; Verma A
J Fam Plann Reprod Health Care; 2016 Apr; 42(2):119-26. PubMed ID: 26590048
[TBL] [Abstract][Full Text] [Related]
38. Cervical smear histories of 500 women with invasive cervical cancer in Yorkshire.
Paterson ME; Peel KR; Joslin CA
Br Med J (Clin Res Ed); 1984 Oct; 289(6449):896-8. PubMed ID: 6434133
[TBL] [Abstract][Full Text] [Related]
39. Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study.
Sundström K; Lu D; Elfström KM; Wang J; Andrae B; Dillner J; Sparén P
Am J Obstet Gynecol; 2017 Jan; 216(1):48.e1-48.e15. PubMed ID: 27457115
[TBL] [Abstract][Full Text] [Related]
40. A case-control study of cervical cancer screening in north east Scotland.
Macgregor JE; Moss SM; Parkin DM; Day NE
Br Med J (Clin Res Ed); 1985 May; 290(6481):1543-6. PubMed ID: 3924157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
